Activating Compound | Comment | Organism | Structure |
---|---|---|---|
2-[[(2-methoxyphenyl)methyl]amino]-2-oxoethyl 2-(furan-2-yl)quinoline-4-carboxylate | - |
Homo sapiens | |
4-[4-[(2-oxo-2,3-dihydro-1H-indol-5-yl)sulfonyl]piperazin-1-yl]benzaldehyde | - |
Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expressed in Escherichia coli BL21 NiCo cells and COS-7 cells | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(2-bromo-4,5-dimethoxyphenyl)(6,7-dimethoxyisoquinolin-1-yl)methanone | about 80% residual activity at 0.01 mM | Homo sapiens | |
1,10-phenanthroline-5,6-dione | about 35% residual activity at 0.01 mM | Homo sapiens | |
1,6-dimethyl-3-propylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione | about 65% residual activity at 0.01 mM | Homo sapiens | |
2-[5-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-3-yl]pyridine | about 18% residual activity at 0.01 mM | Homo sapiens | |
3-(4-methylphenyl)-5H-indeno[1,2-c]pyridazin-5-one | about 55% residual activity at 0.01 mM | Homo sapiens | |
4-(quinoxalin-2-yl)phenyl furan-2-carboxylate | about 75% residual activity at 0.01 mM | Homo sapiens | |
methyl N-[[(4-butyl-2-oxo-2H-1-benzopyran-7-yl)oxy]acetyl]-5-hydroxy-L-tryptophanate | - |
Homo sapiens | |
N'-(4-methoxybenzoyl)pyridine-2-carbohydrazide | about 20% residual activity at 0.01 mM | Homo sapiens | |
N'-[(4-methoxybenzoyl)oxy]pyridine-2-carboximidamide | about 30% residual activity at 0.01 mM | Homo sapiens | |
N-(1H-benzimidazol-2-yl)-2-methoxybenzamide | about 65% residual activity at 0.01 mM | Homo sapiens | |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[[5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | about 40% residual activity at 0.01 mM | Homo sapiens | |
N-[5-[4-(dimethylamino)phenyl]-3-oxo-2,3-dihydro-1H-pyrazol-4-yl]pyridine-2-carboxamide | about 95% residual activity at 0.01 mM | Homo sapiens | |
N-[[(4-butyl-2-oxo-2H-1-benzopyran-7-yl)oxy]acetyl]-5-hydroxy-L-tryptophan | about 20% residual activity at 0.01 mM | Homo sapiens | |
propan-2-yl N-[[(4-butyl-2-oxo-2H-1-benzopyran-7-yl)oxy]acetyl]-5-hydroxy-L-tryptophanate | - |
Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
endosome | - |
Homo sapiens | 5768 | - |
Golgi apparatus | - |
Homo sapiens | 5794 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + 1-phosphatidyl-1D-myo-inositol | Homo sapiens | - |
ADP + 1-phosphatidyl-1D-myo-inositol 4-phosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Purification (Comment) | Organism |
---|---|
Ni-NTA agarose column chromatography and Mono-Q column chromatography | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
HEK-293-AT1 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + 1-phosphatidyl-1D-myo-inositol | - |
Homo sapiens | ADP + 1-phosphatidyl-1D-myo-inositol 4-phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
phosphatidylinositol 4-kinase type II alpha | - |
Homo sapiens |
PI4K2A | - |
Homo sapiens |